Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 12:52 PM UTC
| NCT Number | NCT06958328 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | PHASE3 |
| Target Enrollment | 356 participants |
| Active Locations | 332 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | August 25, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT06958328 is currently recruiting participants. This phase3 study for pancreatic cancer is actively seeking new participants at 332 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06958328 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 332 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06958328 was last updated 1 week ago (August 25, 2026). HelloStudys verifies this status automatically.